Novo Nordisk lowering prices for weight loss, diabetes drugs for cash customers

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy 0.25 mg and 0.5 mg injections and Ozempic will be $199 a month for new self-pay patients until March 31, 2026, Novo Nordisk…